HDAC8 and breast cancer: Chrysin was proven to be an HDAC2/8 dual inhibitor (HDAC2 EC50 = 129.0 μM; HDAC8 EC50 = 40.2 μM), without showing any activity on HDAC1, and was able to suppress cell growth while promoting differentiation in human breast cancer MDA-MB-231 cells.